Nuzenio

Actio

Actio news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 21 latest news signals 20 publisher sources 100/100 entity strength

Latest news

Jazz Pharma Expands Again in Epilepsy With $850M Actio Bio Acquisition - MedCity NewsMedCity News · Mon, 10 Aug 2026 22:02:41 GMTJazz Pharmaceuticals to acquire Actio Biosciences for up to $1.32bn - Eurasia Business NewsEurasia Business News · Mon, 10 Aug 2026 21:37:26 GMTJazz to buy Actio for up to $1.3B, gaining epilepsy asset - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 19:37:19 GMT$1.32 Billion for a Molecule: Jazz Pharmaceuticals Bets on Rare-Epilepsy Drug With No Approved Rivals - USA HeraldUSA Herald · Mon, 10 Aug 2026 19:01:18 GMTJazz Acquires Actio Bioscience | PharmExec - Pharmaceutical ExecutivePharmaceutical Executive · Mon, 10 Aug 2026 18:37:55 GMTJazz Pharmaceuticals Strikes $820 Million Deal for Actio Biosciences to Secure First-in-Class Rare Epilepsy Drug - finance.biggo.comfinance.biggo.com · Mon, 10 Aug 2026 18:22:00 GMTJazz Pharmaceuticals to acquire San Diego biotech for up to $1.3B - The Business JournalsThe Business Journals · Mon, 10 Aug 2026 17:14:00 GMTJazz Pharma Buying Actio In Up To $1.32B Epilepsy Push - Law360Law360 · Mon, 10 Aug 2026 17:05:00 GMT

Timeline

Mon, 10 Aug 2026 22:02:41 GMTJazz Pharma Expands Again in Epilepsy With $850M Actio Bio Acquisition - MedCity News
Mon, 10 Aug 2026 21:37:26 GMTJazz Pharmaceuticals to acquire Actio Biosciences for up to $1.32bn - Eurasia Business News
Mon, 10 Aug 2026 19:37:19 GMTJazz to buy Actio for up to $1.3B, gaining epilepsy asset - FirstWord Pharma
Mon, 10 Aug 2026 19:01:18 GMT$1.32 Billion for a Molecule: Jazz Pharmaceuticals Bets on Rare-Epilepsy Drug With No Approved Rivals - USA Herald
Mon, 10 Aug 2026 18:37:55 GMTJazz Acquires Actio Bioscience | PharmExec - Pharmaceutical Executive
Mon, 10 Aug 2026 18:22:00 GMTJazz Pharmaceuticals Strikes $820 Million Deal for Actio Biosciences to Secure First-in-Class Rare Epilepsy Drug - finance.biggo.com

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Actio.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

20 distinct publisher/source names are currently connected to this entity page.